Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for American Bio Medica Corp. (ABMC : OTC)

• Company Description    American Bio Medica develops, manufactures and markets biomedical technologies and products intended for the immediate, onsite screening for drugs of abuse. Their products offer health care, law enforcement, government, industrial safety and educational professionals, self-contained, one-step screening devices capable of identifying illicit drug use within minutes. Number of Employees: 37

• Price / Volume Information    Yesterday's Closing Price: $0.02 Daily Weekly Monthly 20 Day Moving Average: 58,023 shares Shares Outstanding: 48.10 (millions) Market Capitalization: $0.96 (millions) Beta: -1.36 52 Week High: $0.10 52 Week Low: $0.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.00% -12.67% 12 Week -47.37% -43.12% Year To Date -46.67% -36.83%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 122 SMITH ROAD - KINDERHOOK,NY 12106 USA ph: 518-758-8158 fax: 518-758-8171 ir@abmc.com http://www.abmc.com

• General Corporate Information    Officers Melissa A. Waterhouse - Chief Executive Officer Jean Neff - Director and Corporate Secretary Peter Jerome - Director Peter Jerome - Director Diane J. Generous - Director Peer Information American Bio Medica Corp. (BJCT) American Bio Medica Corp. (CADMQ) American Bio Medica Corp. (APNO) American Bio Medica Corp. (UPDC) American Bio Medica Corp. (IMTIQ) American Bio Medica Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 024600108 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/21 Next Expected EPS Date: 05/19/22 Share - Related Items Shares Outstanding: 48.10 Most Recent Split Date: (:1) Beta: -1.36 Market Capitalization: $0.96 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/19/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.43 EPS Growth vs. Year Ago Period: 300.00% vs. Previous Quarter: 300.00% Sales Growth vs. Year Ago Period: -34.49% vs. Previous Quarter: -17.10% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - -24.68 09/30/21 - -19.50 Current Ratio 03/31/22 - - 12/31/21 - 0.47 09/30/21 - 0.54 Quick Ratio 03/31/22 - - 12/31/21 - 0.32 09/30/21 - 0.40 Operating Margin 03/31/22 - - 12/31/21 - -21.06 09/30/21 - -14.92 Net Margin 03/31/22 - - 12/31/21 - -20.88 09/30/21 - -14.92 Pre-Tax Margin 03/31/22 - - 12/31/21 - -20.78 09/30/21 - -14.88 Book Value 03/31/22 - - 12/31/21 - -0.02 09/30/21 - -0.02 Inventory Turnover 03/31/22 - - 12/31/21 - 3.62 09/30/21 - 3.78 Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©